Pahayahay, Rolando D.
HRN: 20-37-33 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/04/2023
08/11/2023
IV
4.5
Q6HRS
SSI
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes